Breakthroughs, Delivered With Care.
Connecting patients around the world with investigational medicinal products
Early Access Care connects patients who have rare and/or serious medical conditions with investigational medicinal products, when all available treatment options have been exhausted.
We use the FDA or each respective country's expanded access or compassionate use regulatory pathways.
Our experts guide biopharma companies in understanding the latest FDA investigational drug legislation or local regulatory compassionate use pathways to develop and implement the right solution for each investigational medicinal product.
We work directly with physicians in understanding all of the requirements to obtain an investigational drug for each patient expediting the overall process.
We streamline the entire compassionate use request process from submission, review, approval to drug delivery and resupply so biopharma companies can maintain their efforts and resources on their clinical trials.
Experience You Can Trust
Our industry-leading platform gives you a simpler way to implement an expanded access program and gain valuable insights and data, potentially bringing life-saving experimental drug treatments to market faster.
Providing SeRvice Across the Globe
Want to learn more about our Expanded Access Capabilities?